PNC Financial Services Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-242
Closed -$14.2K 4867
2023
Q4
$14.2K Buy
242
+3
+1% +$176 ﹤0.01% 3598
2023
Q3
$10.4K Buy
239
+103
+76% +$4.49K ﹤0.01% 3746
2023
Q2
$4.91K Buy
136
+18
+15% +$650 ﹤0.01% 4116
2023
Q1
$4.39K Sell
118
-9
-7% -$335 ﹤0.01% 4081
2022
Q4
$5.75K Sell
127
-240
-65% -$10.9K ﹤0.01% 3961
2022
Q3
$25K Buy
367
+211
+135% +$14.4K ﹤0.01% 3358
2022
Q2
$11K Sell
156
-89
-36% -$6.28K ﹤0.01% 3784
2022
Q1
$20K Buy
245
+192
+362% +$15.7K ﹤0.01% 3588
2021
Q4
$7K Sell
53
-25
-32% -$3.3K ﹤0.01% 3902
2021
Q3
$15K Buy
78
+27
+53% +$5.19K ﹤0.01% 3631
2021
Q2
$7K Buy
51
+21
+70% +$2.88K ﹤0.01% 3809
2021
Q1
$4K Buy
30
+14
+88% +$1.87K ﹤0.01% 3880
2020
Q4
$4K Buy
+16
New +$4K ﹤0.01% 3775
2020
Q3
Sell
-517
Closed -$59K 4089
2020
Q2
$59K Sell
517
-19,140
-97% -$2.18M ﹤0.01% 2674
2020
Q1
$1.51M Buy
19,657
+4,694
+31% +$361K ﹤0.01% 813
2019
Q4
$1.93M Buy
14,963
+3,713
+33% +$479K ﹤0.01% 823
2019
Q3
$877K Sell
11,250
-85
-0.7% -$6.63K ﹤0.01% 1314
2019
Q2
$1.17M Buy
+11,335
New +$1.17M ﹤0.01% 1219
2018
Q4
Sell
-7,820
Closed -$369K 4212
2018
Q3
$369K Sell
7,820
-5,290
-40% -$250K ﹤0.01% 1846
2018
Q2
$647K Buy
13,110
+13,018
+14,150% +$642K ﹤0.01% 1504
2018
Q1
$3K Hold
92
﹤0.01% 4000
2017
Q4
$2K Hold
92
﹤0.01% 4031
2017
Q3
$1K Buy
+92
New +$1K ﹤0.01% 4096